共 26 条
A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion
被引:115
作者:
Liebowitz, LD
Ashbee, HR
Evans, EGV
Chong, Y
Mallatova, N
Zaidi, M
Gibbs, D
机构:
[1] Giles Sci Inc, Santa Barbara, CA 93140 USA
[2] Univ Witwatersrand, Dept Med Microbiol, ZA-2000 Johannesburg, South Africa
[3] S African Inst Med Res, ZA-2000 Johannesburg, South Africa
[4] Univ Leeds, Div Microbiol, Mycol Reference Ctr, Leeds LS2 9JT, W Yorkshire, England
[5] Yonsei Univ, Coll Med, Severance Hosp, Dept Clin Pathol, Seoul, South Korea
[6] Hosp Ceske Budejovice, Dept Med Microbiol, Ceske Budejovice 37087, Czech Republic
[7] Hosp Gen OHoran, Dept Invest, Merida 97000, Mexico
关键词:
D O I:
10.1016/S0732-8893(01)00243-7
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
The in-vitro activity of fluconazole against 46,831 yeast isolates collected over a two-year period from 57 laboratories in 33 countries worldwide was assessed using a disc diffusion method. Candida albicans was the organism isolated most frequently, accounting for 68.6% of the total number of isolates. C, glabrata, C, tropicalis, C parapsilosis and C. krusei and Cryptococcus neoformans represented 9.9, 4.7, 4.3, 1.9, and 1.4% of isolates respectively during the 2 year period and rates varied markedly between countries. In 1999 data blood isolates represented 4.9% of all isolates and intensive care unit isolates represented 9.9%, In both the 1998 and 1999 data, 99% of C, albicans were fully susceptible (S) to fluconazole, and 95.6% of all species of yeasts tested were S or susceptible-dose dependent (S-DD) to fluconazole. No emerging trends of resistance were noted with any of the Candida spp. tested as 96% of all isolates retained susceptibility (S or S-DD) to this agent. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:27 / 33
页数:7
相关论文